If the corresponding author of a manuscript is a current member of ESOT, they will be eligible for a 40% discount on the publishing fee for all Category A and Category B article types. This applies to all manuscripts which receive final approval for publication from the 1st November 2022.
To apply for this discount, please contact the Editorial Office before or immediately after your manuscript submission: TI@frontierspartnerships.org
Transplant International is the official journal of the European Society for Organ Transplantation (ESOT). Transplant International aims to be the premier journal publishing the key basic science and clinical developments in organ replacement medicine, including all aspects of transplantation, organ reconditioning, cell therapy, regenerative medicine, bioengineering and artificial organs.
Thierry Berney, Emeritus Professor, University of Geneva, Switzerland; Professor of Surgery, Bokeria University Hospital, Ilia State University, Georgia; Program director, islet cell transplantation, Hospices Civils de Lyon, France
Nuria Montserrat, Institute for Bioengineering of Catalonia, Spain
Maarten Naesens, KU Leuven, Belgium
Stefan Schneeberger, Medical University of Innsbruck, Austria
Maria Irene Bellini, Sapienza Universita di Roma, Italy (also Social Media Editor)
Thomas Neyens, KU Leuven, Belgium
Associate Statistical Editor
Maarten Coemans, KU Leuven, Belgium
At Transplant International, we believe that diversity is the essence of humankind. We value engagement and inclusion at all stages of science communication and dissemination, from the submission of research manuscripts, through the editorial and review process and on to publication. We welcome submissions from applicants of all ethnicities, nationalities, religions, gender identities, sexual orientations or other individual status, and are committed to eliminating the influence of any bias in our processes. We recognise that this endeavour requires an ongoing commitment; the journal will continually review its practices in this regard and welcomes any feedback from our authors and community.
Open Access Statement
Transplant International provides online free gold open access to the journal and all of its research publications.
Open Access funder and institutional mandates: Transplant International is fully compliant with open access mandates, by publishing its articles under the Creative Commons Attribution licence (CC-BY). Funder mandates such as those by the Wellcome Trust (UK), National Institutes of Health (USA) and the Australian Research Council (Australia) are fully compatible with publishing in Transplant International. Authors retain copyright of their work and can deposit their publication in any repository. The work can be freely shared and adapted provided that appropriate credit is given and any changes specified.